Cemex Registers 3% Growth In Q4 Sales, Misses On Estimates

  • Cemex SAB De CV CX reported fourth-quarter sales growth of 3% year-over-year (+5% on a like-to-like basis) to $3.62 billion, missing the consensus of $3.73 billion.
  • Sales across markets: Mexico $841 million (+1% Y/Y), U.S. $1.09 billion (+8% Y/Y), EMEA $1.19 billion (+1% Y/Y), and South, Central America and the Caribbean $391 million (+2% Y/Y).
  • Cement volume decreased by 5% Y/Y, ready-mix volume increased 1%, and aggregates volume were flat.
  • Earnings per ADS improved to $0.15 from $0.05 in 4Q20, versus the consensus of $0.19.
  • The gross margin contracted by 110 bps to 30.1%. The operating EBITDA increased by 3% Y/Y to $651 million, and the margin contracted by 10 bps to 18%.
  • Operating expenses as a percentage of net sales decreased by 140 bps to 20% due to lower administrative, sales, distribution, and corporate expenses.
  • The quarter's free cash flow decreased by 54% to $227 million.
  • The leverage ratio was 2.73 times, compared to 2.80 in Q3 and 4.13 times in 4Q20.
  • FY22 Outlook: The company expects operating EBITDA to grow in mid-single digit.
  • Consolidated volume growth is expected to be flat for Cement, low single-digit increase for Ready mix, and low to mid-single digit increase for Aggregates.
  • Price Action: CX shares are trading lower by 3.21% at $5.89 during the market session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!